SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

AGM - Proxy Results

18 Sep 2018 16:00

RNS Number : 1648B
Accsys Technologies PLC
18 September 2018
 

 

AIM: AXS

Euronext Amsterdam: AXS

 

 

18 September 2018

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Result of Annual General Meeting

 

The Board of Accsys Technologies PLC announces that its Annual General Meeting was held at 2:30p.m. (UK time) on the 18 September 2018. All resolutions, as set out in the Notice of Annual General Meeting, dated 8 August 2018 were duly passed.

 

The final proxy voting position is shown below (inclusive of proxy votes cast at the Meeting). Any proxy votes which are at the discretion of the Chairman have been included in the "For" total.

 

No.

Resolutions

(Please refer to Notice of Meeting for full text)

For

Against

Vote Withheld

% Vote Cast For1

 
 

 

Ordinary Resolutions

 

 

 

 

 

1

To receive and adopt the audited financial statements for the financial year ended 31 March 2018, together with the reports of the Directors and auditors

53,100,349 

 -

 1,383

 100%

 

2

To approve the Directors' Remuneration Report for the financial year ended 31 March 2018 (excluding the Remuneration Policy)

53,090,639

6,983

4,110

99.98%

 

3

To approve the Directors' Remuneration Policy with effect from the end of the Annual General Meeting

52,090,499

7,123

1,004,110

99.98%

 

4

To re-elect Trudy Schoolenberg as Director of the Company

53,094,749

6,983

-

99.98%

 

5

To re-elect Susan Jane Mair (known as Sue Farr) as a Director of the Company

53,100,349

1,383

-

99.99%

 

6

To re-elect Michael Sean Christie as a Director of the Company 

53,100,349

1,383

-

99.99%

 

7

To re-appoint PricewaterhouseCoopers LLP as auditors of the Company

53,099,796

-

1,936

100%

 

8

To authorise the Directors to determine the auditors' remuneration

53,100,349

-

1,383

100%

 

9

To authorise the Directors to allot shares generally

53,096,913

2,266

2,553

99.99%

 

 

Special Resolutions

 

 

 

 

 

10

To empower the Directors to allot shares for cash (other than pro rata to existing shareholders)

53,083,856

17,876

-

99.95%

 

11

To authorise the Company to make market purchases of its own ordinary shares

53,083,939

16,993

800

99.96%

 

 

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser:

Jamie Lillywhite

 

Corporate Broking:

Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

+31 681 734 236

+31 222 379 666

 

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

 

 

1 Discounting Votes Withheld

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEALNPFSXPEFF
Date   Source Headline
31st Mar 20087:00 amRNSDirector's Interests
28th Mar 20087:01 amRNSDirector's Interests
25th Mar 20087:01 amRNSFull License Agreement
14th Mar 20087:00 amRNSNotifiable Interest
12th Mar 20083:16 pmRNSHolding(s) in Company
11th Mar 20087:00 amRNSNorwegian Agency Agreement
12th Feb 20087:00 amRNSQuarterly Performance Update
31st Jan 20087:01 amRNSTotal Voting Rights
10th Jan 200812:05 pmRNSAdditional Listing
11th Dec 20077:01 amRNSUAE Rights & Expand Capacity
21st Nov 20077:01 amRNSInterim Results
20th Nov 20077:15 amRNSChina License Agreement
20th Nov 20077:01 amRNSNew Business Relationship
15th Oct 20077:00 amRNSLicense Option Agreement
11th Oct 20074:19 pmRNSDirector/PDMR Shareholding
11th Oct 20072:00 pmRNSDirector/PDMR Shareholding
11th Oct 20077:00 amRNSAppointment of new CEO
28th Sep 20077:00 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSDirector's Interests
18th Sep 20077:02 amRNSEuronext Amsterdam Admission
13th Sep 20072:53 pmRNSSUPPLEMENTARY PROSPECTUS
5th Sep 20077:01 amRNSAdditional Listing
4th Sep 20077:02 amRNSProposed Listing
3rd Sep 20077:01 amRNSChina Option Agreement
20th Aug 20077:00 amRNSLISTING ON EURONEXT AMSTERDAM
17th Aug 20077:00 amRNSNew Appointment
16th Aug 20077:00 amRNSHolding(s) in Company
2nd Aug 20076:05 pmRNSTotal Voting Rights
27th Jul 200710:00 amRNSAdditional Listing
28th Jun 20077:01 amRNSPRELIMINARY RESULTS
25th Jun 20077:02 amRNSAgreement
21st Jun 20074:59 pmRNSHolding(s) in Company
4th Jun 20077:01 amRNSHolding(s) in Company
31st May 20077:01 amRNSTotal Voting Rights
24th May 20072:07 pmRNSHolding(s) in Company
23rd May 20079:14 amRNSAppointment
21st May 200711:49 amRNSCompletion of Subscription
16th May 20077:01 amRNSDirectors Options
15th May 20073:19 pmRNSEGM Statement
30th Apr 20072:13 pmRNSTotal Voting Rights
24th Apr 20077:01 amRNSDirector/Notifiable Interests
11th Apr 20077:01 amRNSPosting of circular
2nd Apr 20077:00 amRNSDirector/PDMR Shareholding
28th Mar 20072:18 pmBUSCelanese Corporation Announces Strategic Partnership with Accsys Technologies for Innovative Use of Acetyl Products
28th Mar 20077:04 amRNSStrategic Partnership
19th Mar 20077:02 amRNSProduction commences
6th Feb 20077:00 amRNSHolding(s) in Company
10th Jan 20077:01 amRNSNew Contract
15th Dec 20064:09 pmRNSTotal Voting Rights
13th Dec 200612:52 pmRNSInterim Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.